Catherine Abi-Habib - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investors  arrow down
    < Back
    • Investors
    • Financial Results
    • Corporate News
    • Financial Calendar

    • Investor Events
    • Reports and Accounts
    • Regulated Information
    • Combined Shareholders’ Meeting 2024 (pre announcement page launch)

      Featured Image
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
  1. Home
  2. Company
  3. Leadership Team
  4. leadership

Catherine Abi-Habib

Back
Catherine Abi-Habib

Catherine Abi-Habib

  • Executive Vice President,
  • Strategy, Transformation and Digital
  • Follow in LinkedIn

Catherine Abi-Habib joined Ipsen in 2022 as Executive Vice President, Strategy, Transformation and Digital.

Prior to joining Ipsen, Catherine spent more than 10 years working with pharmaceutical and biotech companies, health systems, payors, providers, and charitable foundations. She joined Ipsen from McKinsey, where she was a Partner in the Life Sciences practice based in London. Working closely with QuantumBlack, McKinsey’s advanced analytics firm, she partnered with leading biopharma companies on large-scale digital and analytics driven transformations across North America, Europe and Asia, focused on improving physician experience.

Catherine holds an MSc. in Economics from the London School of Economics and a BA in Mathematics from the University of Cambridge, Trinity College.

Related stories

Ipsen FY/Q4 2022 results–A word from CEO David Loew
09 February 2023 1 mins read

Ipsen FY/Q4 2022 results–A word from CEO David Loew

Related assets

Ipsen sites – Wrexham, UK

Ipsen sites – Wrexham, UK

IPN price

€101.90

 €-1.10 (-1.07%)

  • Media
  • Investors
  • Partnering
  • Careers
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us

Global
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2023

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue